Senior insider sale
Chief Financial Officer at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$42.9K
2.08K shares
What this filing means
GOLDAN KEITH A. plans to sell 2.08K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $42.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/6/2026ACC: 0001959173-26-000723
Officer· Chief Financial Officer
Since Jun 2022
2.08K
Shares to sell
$42.9K
Approx. market value
2.08K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/5/2026
2.08KTotal acquired2.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/5/2026 | Restricted Stock Vesting Compensation | 2.08K | — |
| Total | 2.08K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.08K
Market value
$42.9K
2/6/2026
Total
Units
2.08K
Value
$42.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/6/2026 | 2.08K | $42.9K | NASDAQ | Planned |
| Total | 2.08K | $42.9K | ||